Myeloma patient NK cell dysfunction is driven by impaired immune signalling

Published: 20-04-2020| Version 1 | DOI: 10.17632/tw2xm5wwg3.1
Contributor:
Simon Keam

Description

Normalised RNAseq data from FACS sorted healthy donor and patient Natural killer cells with either CD57- or CD57+ expression

Files